|Solubility:||DMSO ≥20 mg/mL|
|Long-term Storage:||at -20°C|
|HPLC:||Shows Min 99.74% purity|
|H-NMR:||Consistent with structure|
|Description:||Dacomitinib (PF-00299804) is an oral, irreversible, small molecule inhibitor of human epidermal growth factor receptor-1, -2, and -4 tyrosine kinases.|
|Stability and Solubility Advice:|| Information concerning product stability, particularly in solution, has rarely been reported and in most cases we can only offer a general guide.
We recommend that stock solutions, once prepared, are stored aliquoted in tightly sealed vials at -20°C or below and used within 1 month.